A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies - Garcês, Sandra; Antunes, Marília; Benito-Garcia, Elizabeth; da Silva, José Canas; Aarden, Lucien; Demengeot, Jocelyne (Annals of the rheumatic diseases, 2014)
Keywords: Adalimumab; Adult; Aged; Algorithms; Antibodies - immunology; Antibodies, Monoclonal - immunology; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized - immunology; Antibodies, Monoclonal, Humanized - therapeutic use; Antirheumatic Agents - immunology; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - immunology; Biological Products - immunology; Clinical medicine; Disease Management; Etanercept; Female; Gangrene; Humans; Immunoglobulin G - immunology; Immunoglobulin G - therapeutic use; Immunoglobulins; Infliximab; Male; Middle Aged; Receptors, Tumor Necrosis Factor - immunology; Receptors, Tumor Necrosis Factor - therapeutic use; Response rates; Rheumatology; Studies; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha - antagonists & inhibitors; Tumor necrosis factor-TNF; Rheumatoid Arthritis; Anti-TNF; DMARDs (biologic)